The aim of the agreement is to analyse the molecules synthesised by IQCC researchers over the past three decades to determine whether they may have therapeutic properties. Barcelona, April 24,…
CIPsee is a new Chemical Intellectual Property lens to search, analyse, and expand molecules in patent documents. Explore the chemical IP space of over 15M biologically-relevant core molecules exemplified in…
Transformative new scientific information capabilities combine an unparalleled collection of curated science data with advanced predictive models to accelerate early-stage drug discovery innovation Columbus, OH, May 21, 2024 – Today,…
Synergizing AI and Multiscale Modeling for Drug Discovery The 24th EuroQSAR Symposium is organised on behalf of QCMS and is chaired by our Founder and CSO, Dr. Jordi Mestres (University of Girona). Also our…
Bridging Boundaries: Innovating, Connecting and Reshaping Drug Repurposing Join the first international drug repurposing conference, #iDR24, co-organised by REMEDi4ALL, Beacon and MeRIT on 6-7 March 2024 in Barcelona. In this global…
CAS, an American Chemical Society division that specializes in scientific information solutions, announced today the formation of its CAS Life Sciences Advisory Board in order to reimagine the future of…
Stanford University has recently published an update of the list of the top 2% most widely cited scientists in different disciplines, the World’s Top 2% Scientists. This ranking, considered the most…
Chemotargets representatives took a “worldwide tour” during September and October 2022, to showcase Chemotargets products and services at different conferences and meetings. In Montréal, Canada, our CSO Jordi Mestres participated…
Chemotargets will contribute to the development of the repurposing platform for the REMEDi4ALL project, using its technology platforms: ProSurfScan, for AI-based drug design; CLARITY, for efficacy and safety prediction of…
© 2026 Chemotargets. Copyright and Legal Notice - Cookie Policy